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Abstract
Treatment and control of schistosomiasis still rely on only one effective drug, praziquantel
(PZQ) and, due to mass treatment, the increasing risk of selecting for schistosome strains
that are resistant to PZQ has alerted investigators to the urgent need to develop novel thera-
peutic strategies. The histone-modifying enzymes (HMEs) represent promising targets for
the development of epigenetic drugs against Schistosoma mansoni. In the present study,
we targeted the S. mansoni lysine-specific demethylase 1 (SmLSD1), a transcriptional core-
pressor, using a novel and selective synthetic inhibitor, MC3935, which was used to treat
schistosomula and adult worms in vitro. By using cell viability assays and optical and elec-
tron microscopy, we showed that treatment with MC3935 affected parasite motility, egg-lay-
ing, tegument, and cellular organelle structures, culminating in the death of schistosomula
and adult worms. In silico molecular modeling and docking analysis suggested that MC3935
PLOS NEGLECTED TROPICAL DISEASES
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008332 July 1, 2020 1 / 29
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Coutinho Carneiro V, de Abreu da Silva IC,
Amaral MS, Pereira ASA, Silveira GO, Pires DdS, et
al. (2020) Pharmacological inhibition of lysine-
specific demethylase 1 (LSD1) induces global
transcriptional deregulation and ultrastructural
alterations that impair viability in Schistosoma
mansoni. PLoS Negl Trop Dis 14(7): e0008332.
https://doi.org/10.1371/journal.pntd.0008332
Editor: Wei Hu, Fudan University School of Life
Sciences, CHINA
Received: November 8, 2019
Accepted: April 28, 2020
Published: July 1, 2020
Peer Review History: PLOS recognizes the
benefits of transparency in the peer review
process; therefore, we enable the publication of
all of the content of peer review and author
responses alongside final, published articles. The
editorial history of this article is available here:
https://doi.org/10.1371/journal.pntd.0008332
Copyright: © 2020 Coutinho Carneiro et al. This is
an open access article distributed under the terms
of the Creative Commons Attribution License,
which permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
binds to the catalytic pocket of SmLSD1. Western blot analysis revealed that MC3935 inhib-
ited SmLSD1 demethylation activity of H3K4me1/2. Knockdown of SmLSD1 by RNAi reca-
pitulated MC3935 phenotypes in adult worms. RNA-Seq analysis of MC3935-treated
parasites revealed significant differences in gene expression related to critical biological pro-
cesses. Collectively, our findings show that SmLSD1 is a promising drug target for the treat-
ment of schistosomiasis and strongly support the further development and in vivo testing of
selective schistosome LSD1 inhibitors.
Author summary
Schistosomiasis mansoni is a chronic and debilitating tropical disease caused by the hel-
minth Schistosoma mansoni. The control and treatment of the disease rely almost exclu-
sively on praziquantel (PZQ). Thus, there is an urgent need to search for promising
protein targets to develop new drugs. Drugs that inhibit enzymes that modify the chroma-
tin structure have been developed for a number of diseases. We and others have shown
that S. mansoni epigenetic enzymes are also potential therapeutic targets. Here we evalu-
ated the potential of the S. mansoni histone demethylase LSD1 (SmLSD1) as a drug target.
We reported the synthesis of a novel and potent LSD1 inhibitor, MC3935, and show that
it selectively inhibited the enzymatic activity of SmLSD1. Treatment of juvenile or adult
worms with MC3935 caused severe damage to the tegument of the parasites and compro-
mised egg production. Importantly, MC3935 proved to be highly toxic to S. mansoni, cul-
minating in the death of juvenile or adult worms within 96 h. Transcriptomic analysis of
MC3935-treated parasites revealed changes in the gene expression of hundreds of genes
involved in key biological processes. Importantly, SmLSD1 contains unique sequences
within its polypeptide chain that could be explored to develop a S. mansoni selective drug.
Introduction
Schistosomes are large metazoan pathogens that parasitize over 200 million people worldwide,
resulting in up to 300,000 deaths per year [1,2]. No efficacious vaccine is available for human
schistosomiasis, and the control and treatment of the disease rely almost exclusively on prazi-
quantel (PZQ), the only effective drug against all schistosome species infecting humans.
Despite its efficacy, PZQ does not kill juvenile parasites, allowing reinfection [3], and there is a
constant concern with the appearance of PZQ-resistant strains of Schistosoma [4–6]. Thus,
there is an urgent need to search for promising protein targets to develop new drugs.
Transcription factors and chromatin modifiers play primary roles in the programming and
reprogramming of cellular states during development and differentiation, as well as in main-
taining the correct cellular transcriptional profile [7]. Indeed, a plethora of groundbreaking
studies has demonstrated the importance of posttranslational modifications of histones for
transcription control and normal cell development. Therefore, the deregulation of epigenetic
control is a common feature of a number of diseases, including cancer [7].
The complexity of schistosome development and differentiation implies tight control of
gene expression at all stages of the life cycle and that epigenetic mechanisms are likely to play
key roles in these processes. In recent years, targeting the Schistosoma mansoni epigenome has
emerged as a new and promising strategy to control schistosomiasis. The study of histone acet-
ylation in S. mansoni biology and the effect of inhibitors of histone deacetylases (HDACs and
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SIRTs) or histone acetyltransferases (HATs) on parasite development and survival have dem-
onstrated the importance of these enzymes as potential therapeutic targets [8–12].
Unlike histone lysine acetylation, which is generally coupled to gene activation, histone
lysine methylation can have different biological associations depending on the position of the
lysine residue and the degree of methylation [13]. Patterns of specific lysine methyl modifica-
tions are achieved by a precise lysine methylation system, consisting of proteins that add,
remove and recognize the specific lysine methyl marks. Importantly, histone lysine methyla-
tion [14–16] and demethylation [17] have been recently demonstrated to be potential drug tar-
gets against S. mansoni.
Lysine-specific demethylase 1 (LSD1) was the first protein reported to exhibit histone
demethylase activity and has since been shown to have multiple essential roles in metazoan
biology [18]. LSD1 enzymes are characterized by the presence of an amine oxidase (AO)-like
domain, which is dependent on its cofactor flavin-adenine dinucleotide (FAD), a SWIRM
domain, which is unique to chromatin-associated proteins [19] and an additional coiled-coil
TOWER domain [20]. LSD1 is a component of the CoREST transcriptional corepressor com-
plex that also contains CoREST, CtBP, HDAC1 and HDAC2. As part of this complex, LSD1
demethylates mono-methyl and di-methyl histone H3 at Lys4 (H3K4me1/2), but not
H3K4me3 [21]. In addition, when recruited by androgen or estrogen receptor, LSD1 functions
as a H3K9 demethylase. Given the high level of expression and enzymatic activity of LSD1 in
many types of tumors, there has been significant recent interest in the development of pharma-
cological inhibitors [22].
In our continuing effort to study the biology and therapeutic potential of epigenetic regula-
tors in S. mansoni, we have found schistosome LSD1 (SmLSD1, Sm_150560) as a potential
drug target (this paper). During the course of our investigation, a recent publication [17]
described the repurposing of some anthracyclines as anti-Schistosoma agents, suggesting by in
silico docking SmLSD1 as a putative target without any evidence of enzyme inhibition.
In the present work we show the SmLSD1-inhibitory activity of a novel synthetic LSD1
inhibitor MC3935 (100-fold more potent than the canonical human LSD1 inhibitor tranylcy-
promine, TCP). In addition, we show that the LSD1 inhibitor MC3935 was able to kill both
adult worms and schistosomula in vitro. Importantly, silencing of SmLSD1 by dsRNAi par-
tially recapitulated MC3935-treatment phenotypes in adult worms. Our RNA-Seq analysis
revealed a large-scale transcriptional deregulation in parasites that were treated with sublethal
doses of MC3935, which could be the primary cause of the ultrastructure defects and death of
S. mansoni. Together, these findings elucidate the biological relevance of histone lysine methyl-
ation in S. mansoni and provide insights into the therapeutic potential of SmLSD1 to control
schistosomiasis.
Materials and methods
Ethics statement
Animals were handled in strict accordance with good animal practice as defined by the Animal
Use Ethics Committee of UFRJ (Universidade Federal do Rio de Janeiro). This protocol was
registered at the National Council for Animal Experimentation (CONCEA- 01200.001568/
2013-87) with approval number 086/14. The study adhered to the institution’s guidelines for
animal husbandry.
Protein alignment and phylogenetic relationships
Multiple-sequence alignment of the full-length proteins was performed using representatives
of C. elegans (NP_493366.1), D. melanogaster (NP_649194.1), H. sapiens (NP_055828.2), M.
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musculus (NP_598633.2), D. rerio (XP_005158840.1), A. thaliana (NP_187981.1), S. japonicum
(TNN15244.1), S. haematobium (XP_012793780.1), and S. mansoni (Smp_150560) LSD1 pro-
tein sequences, as previously published [23]. Pairwise comparisons to the reference followed
by calculation of the maximum distance matrix resulted in an unrooted phylogenetic tree,
which was visualized using Tree of Life v1.0 [24].
Chemistry
Compound MC3935 (S1A Fig) was synthesized by coupling of the racemic tert-butyl (2-
(4-aminophenyl)cyclopropyl)carbamate, prepared as previously reported [25], with the com-
mercially available 4-ethynylbenzoic acid, followed by acidic deprotection of the Boc-protected
amine.
1H-NMR spectra were recorded at 400 MHz using a Bruker AC 400 spectrometer; chemical
shifts are reported in ppm units relative to the internal reference tetramethylsilane (Me4Si).
Mass spectra were recorded on an API-TOF Mariner by Perspective Biosystem (Stratford,
Texas, USA). Samples were injected by a Harvard pump at a flow rate of 5–10 μL/min and
infused into the electrospray system. All compounds were routinely checked by TLC and
1H-NMR. TLC was performed on aluminum-backed silica gel plates (Merck DC, Alufolien
Kieselgel 60 F254) with spots visualized by UV light or using a KMnO4 alkaline solution. All
solvents were reagent grade and, when necessary, were purified and dried by standard meth-
ods. The concentration of solutions after reactions and extractions involved the use of a rotary
evaporator operating at a reduced pressure of ~ 20 Torr. Organic solutions were dried over
anhydrous sodium sulfate. Elemental analysis was used to determine the purity of the final
compound 1 (MC3935) which was >95%. Analytical results were within 0.40% of the theoreti-
cal values. As a rule, the sample prepared for physical and biological studies was dried in high
vacuum over P2O5 for 20 h at temperatures ranging from 25 to 40˚C. Abbreviations are
defined as follows: dimethylformamide (DMF), N-(3-dimethylaminopropyl)-N0-ethylcarbodii-
mide (EDCI), 1-hydroxybenzotriazole hydrate (HOBt), triethylamine (TEA), ethyl acetate
(EtOAc) and tetrahydrofuran (THF).
Preparation of tert-Butyl- (trans-2(4-(4-ethynylbenzamido)phenyl)
cyclopropyl) carbamate (3)
4-Ethynylbenzoic acid (135.4 mg, 0.93 mmol, 1.15 eq), EDCI (216.2 mg, 1.13 mmol, 1.4 eq),
HOBt (152.4 mg, 1.13 mmol, 1.4 eq) and TEA (0.43 mL, 3.06 mmol, 3.8 eq) were added
sequentially to a solution of 2 (200 mg, 0.805 mmol, 1.0 eq) in dry DMF (4.5 mL) (S1 Fig). The
resulting mixture was then stirred for approximately 7 h at room temperature and, after com-
pletion of the reaction, quenched with NaHCO3 saturated solution (40 mL). The aqueous solu-
tion was extracted with EtOAc (4 x 25 mL); washed with 0.1 N KHSO4 solution (2 x 10 mL),
NaHCO3 saturated solution (3 x 10 mL) and brine (3 x 5 mL); dried over anhydrous Na2SO4
and finally concentrated under vacuum. The crude product was then purified by column chro-
matography on silica gel eluting with a mixture EtOAc:hexane 25:75 to afford 3 as a pink solid
(193 mg, 64%). 1H-NMR (400 MHz, CDCl3): δ 1.06–1.10 (m, 2H, -CH2-), 1.39 (s, 9H, -COO
(CH3)3), 1.94–1.98 (m, 1H, Ar-CH-), 2.63 (m, 1H, -CH-NH-COO(CH3)3), 3.16 (s, 1H,
HC�C-), 4.78 (s, 1H, -NH-COO(CH3)3), 7.07–7.09 (d, 2H, H-Ar), 7.44–7.47 (d, 2H, H-Ar),
7.52–7.54 (d, 2H, H-Ar), 7.69 (s, 1H, Ar-CO-NH-Ar), 7.74–7.76 (d, 2H, H-Ar). MS (ESI), m/z:
377 [M + H]+.
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Preparation of N-(4-(trans-2-aminocyclopropyl)phenyl)-
4-ethynylbenzamide hydrochloride (1, MC3935)
To a solution of 3 (125 mg, 0.332 mmol, 1 eq.) in dry THF (9 mL) was added 4N HCl in diox-
ane (5.4 mL, 21.6 mmol, 65 eq.) while cooling at 0˚C. Then, the resulting suspension was stir-
red at room temperature for approximately 1 h. Finally, the suspension was filtered off and
washed over the filter in sequence with dry THF (1 x 3 mL) and dry diethyl ether (4 x 3 mL) to
afford 1 (MC3935) as a slightly pink solid (90.8 mg, 87.5%). 1H-NMR (400 MHz, DMSO-d6): δ
1.16–1.21 (m, 1H, -CHH-), 1.33–1.38 (m, 1H, -CHH-), 2.26–2.31 (m, 1H, -CH-Ar), 2.77–2.80
(m, 1H, -CH-NH2�HCl), 4.43 (s, 1H, HC�C-), 7.14–7.16 (d, 2H, H-Ar), 7.63–7.65 (d, 2H, H-
Ar), 7.70–7.72 (d, 2H, H-Ar), 7.95–7.98 (d, 2H, H-Ar), 8.28 (br s, 3H, -CH-NH2�HCl), 10.33 (s,
1H, Ar-CONH-Ar). MS (ESI), m/z: 277 [M + H]+. Anal. (C18H17ClN2O) Calcd. (%): C, 69.12;
H, 5.48; Cl, 11.33; N, 8.96. Found (%) C, 69.26; H, 5.50; Cl, 11.27; N, 8.87.
Biochemistry
Human LSD1 (KDM1A) (lysine (K)-specific demethylase 1A) was purchased from BPS Biosci-
ence (catalog No 50097). Monomethylated histone peptide H3K4N(CH3) was purchased from
Pepscan and horseradish peroxidase (HRP) from Pierce (Catalog No. 31490). The reagents for
buffer preparation were purchased from Merck, Netherlands. Reactions were conducted in
black 96-well flat-bottom microplates (Corning). The fluorescence measurements were carried
out in a Synergy H1 Hybrid Multi-Mode Microplate Reader (BioTek, USA) and the gain set-
ting of the instrument was adjusted to 70. GraphPad Prism 5.0 was used for determination of
the half-maximal inhibitory concentration (IC50). Nonlinear regression was used for data
fitting.
Human LSD1 inhibition assay
Compound 1 (MC3935) was screened for inhibition against human recombinant LSD1. The
in vitro assay was based on the oxidative demethylation of the monomethylated histone pep-
tide H3K4N(CH3) via a FAD/FADH2 mediated reduction of O2 to H2O2. The remaining
LSD1 activity was monitored via the detection of the amount of H2O2 formed. This was done
by horseradish peroxidase (HRP), which reduces H2O2 to H2O using Amplex Red
2 as the elec-
tron donor. The resulting product, resorufin, was highly fluorescent at 590 nm. The inhibition
assay was performed as described previously [26]. The compound was preincubated at differ-
ent concentrations with LSD1 for 15 min at room temperature in the presence of HRP-Amplex
Red. The substrate was then added, and the fluorescence was measured for 30 min.
Homology modeling
The amino acid sequence of SmLSD1 was retrieved from Uniprot [27] (accession number:
G4VK09). Subsequently, alignment of SmLSD1 and HsLSD1 sequences was performed using
MOE version 2018.01 (Molecular Operating Environment (MOE), 2018.01; Chemical Comput-
ing Group Inc., Canada). Long inserts in the sequence of SmLSD1 (aa: 205–271, 324–385,
828–860, 883–910, and 965–983) were deleted and consequently not modeled. The saved
alignment file was used to generate a homology model of SmLSD1 based on the cocrystal
structure of hLSD1 with MC2580 (PDB ID 2XAS) [26] using MODELLER 9.11 [28].
Ligand preparation
Similar to the observed adduct of the analogous tranylcypromine derivative MC2584 with
FAD (PDB ID 2XAQ [29]), an N5 adduct of MC3935 with FAD was generated in MOE using
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only the flavin ring of FAD. The generated adduct was then cured using LigPrep (Schro¨dinger
Release 2018–1): protonation states were assigned at pH 7±1 using Epik, tautomeric forms, as
well as possible conformers were generated, and energy minimized using the OPLS03 force
field. As a result, 25 low-energy conformers were generated using the bioactive search module
implemented in Schro¨dinger.
Protein preparation
The generated homology model of SmLSD1 was prepared with Schro¨dinger’s Protein Prepara-
tion Wizard (Schro¨dinger Release 2018–1); where hydrogen atoms were added and the hydro-
gen bond network was optimized. The protonation states at pH 7.0 were predicted using the
PROPKA tool in Schro¨dinger, and the structure was subsequently subjected to a restrained
energy minimization using the OPLS03 force field (RMSD of the atom displacement for termi-
nating the minimization was 0.3 Å).
Docking
The receptor grid preparation for the docking procedure was carried out by assigning the
coordinates of the cut cocrystallized adduct (only the flavin ring was kept in FAD) as the cen-
troid of the grid box. Molecular docking was performed using Glide (Schro¨dinger Release
2018–1) in the Standard Precision mode. A total of 20 poses per ligand conformer were
included in the postdocking minimization step, and a maximum of one docking pose was
stored for each conformer.
Parasite stock
The Belo Horizonte strain of Schistosoma mansoni (Belo Horizonte, Brazil) was maintained in
the snail (Biomphalaria glabrata) as the intermediate host and the golden hamster (Mesocrice-
tus auratus) as the definitive host [30]. Female hamsters aged 3–4 weeks, weighing 50–60 g,
were infected by exposure to a S. mansoni cercarial suspension containing approximately 250
cercariae using intradermal injection. The adult worms were obtained by hepatoportal perfu-
sion at 42–49 days postinfection. Cercariae were released from infected snails and mechani-
cally transformed to obtain schistosomula in vitro [31].
Treatment of S. mansoni with LSD1 inhibitors
Schistosomula or adult worms were treated with different concentrations of LSD1 inhibitors,
as indicated in the figure legends. For each treatment condition, 10 worm pairs were main-
tained in 60-mm diameter culture dishes in 2 mL of culture medium (medium M169 (Gibco)
supplemented with 10% fetal bovine serum (Vitrocell), penicillin/streptomycin, amphotericin
and gentamicin (Vitrocell). Schistosomula were maintained in 96-well or 24-well culture
plates, depending on the experiment, with 200 μL or 1 mL of culture medium M169 (Gibco),
respectively, supplemented with 2% fetal bovine serum (Vitrocell), 1 μM serotonin, 0.5 μM
hypoxanthine, 1 μM hydrocortisone, 0.2 μM triiodothyronine, penicillin/streptomycin,
amphotericin and gentamycin (Vitrocell). Parasites were maintained at 37˚C in 5% CO2 with a
humid atmosphere. The medium containing the LSD1 inhibitors or DMSO (vehicle) was
refreshed every 24 h during the treatment period (1–4 days).
Viability assay
An inverted stereomicroscope (Leica M80) was used to evaluate the physiology and behavior
of the parasites. Parasites were observed every 24 h, and representative images and videos were
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acquired. Schistosomula motility, light opacity, and membrane integrity were evaluated. Adult
worm motility, pairing state, adherence to dish surface, and egg laying were monitored and
determined. The viability was determined using the CellTiter-Glo Luminescent Cell Viability
Assay (Promega) [32]. One thousand schistosomula or 10 paired adult worms´ total cell lysate
were submitted to ATP dosage. Eggs laid on the plates were quantified daily and plotted as the
ratio of eggs laids per day normalized by the number of coupled worms observed. The com-
pound concentration required to cause mortality in 50% of schistosomula in culture was deter-
mined using methods previously described [11]. Briefly, 2000 schistosomula were incubated
with different concentrations of MC3935. After 24 h, Alamar Blue reagent (Invitrogen) was
added according to the manufacturer’s instructions, and the mixture was incubated again for
21 h before samples were analyzed. Detection of viable parasites, which convert the resazurine
compound of the reagent into the highly fluorescent resorufin, was performed using a FLUOs-
tar OPTIMA microplate reader (BMG Labtec, Ortenberg, Germany) with the following filter
set: Ex 560 nm/Em 590 nm. All of the measurements were performed in triplicate.
SmLSD1 mRNA quantification
After treatment, the total RNA was extracted using a RiboPure kit (Ambion) followed by
DNase treatment (Ambion) and cDNA synthesis (Superscript III, Invitrogen), following the
manufacturer’s instructions. The resulting cDNA was diluted 10-fold in water and qPCR
amplification was performed with 5 μL of diluted cDNA in a total volume of 15 μL using SYBR
Green Master Mix (Life Technologies) and specific primer pairs listed in S12 Table were
designed for S. mansoni genes by Primer3 online software (http://www.bioinformatics.nl/cgi-
bin/primer3plus/primer3plus.cgi). QuantStudio 3 Real-Time PCR System (Applied Biosys-
tems) was used. The results were analyzed by the comparative Ct method, the graphs were
plotted using GraphPad Prism 8 software, and statistical significance was calculated with the
Student´s t-test.
Western blotting
Nuclear protein extracts from schistosomula or adult worms were prepared as previously
described [31]. From each sample, 10 μg of each extract was loaded on 7–12% precast SDS-
polyacrylamide gels (Bio-Rad). After transference, membranes were blocked with Tris-buff-
ered saline (TBS) containing 0.1% Tween 20 and 2% bovine serum albumin (TBST/2% BSA)
and then probed overnight with specific antibodies in TBS/2% BSA. Membranes were washed
with TBST and incubated for 1 h in TBST/2% BSA with secondary antibody (Immunopure
goat anti-mouse # 31430, Thermo Scientific, and peroxidase-labeled affinity anti-rabbit # 04-
15-06, KPL). After washing the membranes in TBST, the bands were visualized and images
were recorded with the Amersham Imaging System (GE Healthcare), and quantified with Ima-
geJ software (NIH). Histone monoclonal antibodies used were anti-H3K4me1 (#5326, Cell Sig-
naling), anti-H3K4me2 (#9725, Cell Signaling) and anti-H3K4me3 (#9727, Cell Signaling),
following the manufacturer’s instructions. For all antibodies, a 1:1000 dilution was used. For
normalization of the signals across the samples, anti-histone H3 antibody (#14269, Cell Signal-
ing) was used.
Caspase 3/7 activity
The activity of caspase 3/7 was measured using the Caspase-Glo 3/7 assay kit (Promega) fol-
lowing the instructions. Cell lysates from schistosomula were obtained from 2,000 parasites
cultivated in a 24-well plate with complete medium (as described above) and treated with
MC3935 25 μM or vehicle (DMSO 0.25%). The luminescence was measured in a white-walled
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96-well plate in a Wallac Victor2 1420 multilabel counter (PerkinElmer). The graphs were
plotted using GraphPad Prism 8 software, and statistical significance was calculated with the
Student´s t-test.
TUNEL assay
Detection of DNA strand breaks in MC3935-treated schistosomula was performed using the
In situ Cell Death Detection kit (Roche), as previously described [33]. Schistosomula were
fixed after 72 h treatment with MC3935 or DMSO. Parasites were mounted in a superfrost
glass slide using Prolong with DAPI (Invitrogen) for nuclear visualization. Images were taken
on a Zeiss Axio Observer Z1 (Zeiss) inverted microscope equipped with a 40X objective lens
and an AxioCam MRm camera in ApoTome mode.
Confocal laser scanning microscopy
For the confocal microscopy analysis, the adult worms were fixed and stained as previously
described [34]. Confocal scanning laser microscopy was performed on a Zeiss LSM 800 micro-
scope equipped with a 488 nm HE/Ne laser and a 470 nm long-pass filter but without the
reflection mode. Each slide was analyzed by two independent examiners, and 20 samples were
documented to describe the overall observed phenotype.
Scanning and transmission electron microscopy
Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) were per-
formed to analyze ultrastructural alterations in the parasites. Adult worms or schistosomula
were incubated with 25 μM MC3935 or 0.25% DMSO for 48 or 72h, and fixed, as previously
described [34]. For SEM analysis, the samples were dehydrated with increasing concentrations
of ethanol and then dried with liquid CO2 in a critical-point dryer machine (Leica EM
CPD030, Leica Microsystems, Illinois, USA) [35]. Treated specimens were mounted on alumi-
num microscopy stubs and coated with gold particles using an ion-sputtering apparatus (Leica
EM SCD050, Leica Microsystems). Specimens were then observed and photographed using an
electron microscope (FEI QUANTA 250, Thermo Fisher Scientific). TEM analysis was per-
formed on a Tecnai G2 microscope (FEI Company). Fixed specimens were washed in 0.1 M
cacodylate buffer, pH 7.2; postfixed in 1% OsO4 and 0.8% K3Fe (CN)6; washed in 0.1 M caco-
dylate buffer, pH 7.2; dehydrated in a graded acetone series (20˚–100˚ GL) for one hour each
step and embedded in Polybed 812 epoxide resin. Ultra-thin sections (60 nm) were collected
on copper grids and stained for 30 minutes in 5% aqueous uranyl acetate and for 5 minutes in
lead citrate. Each grid was analyzed by two independent examiners, and 20 samples were docu-
mented to described the overall observed phenotype.
Double stranded RNA interference (RNAi)
The coding sequence of lysine-specific histone demethylase 1 (SmLSD1) (GenBank accession
#: XM_018797592.1) was amplified by PCR using the oligonucleotides listed in S12 Table, with
adult parasite cDNA synthesized using 5 ng of total RNA as template. Two different amplicons
(SmLSD1_1 and SmLSD1_2) were used in a second PCR (nested PCR), diluted 1:500, with the
oligonucleotides containing an upstream T7 tail sequence (primers are listed in S12 Table).
The GFP gene was used as a nonrelated dsRNA control and was amplified from pEGFP-N3.
Double-stranded RNA (dsRNA) was synthesized from templates of amplified PCR with oli-
gonucleotides containing the T7 tail. The dsRNA was delivered by soaking the parasite couples
in media containing 30 μg/mL of the desired dsRNA, and everyday, 70% of the medium was
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changed to a fresh medium also containing 30 μg/mL of dsRNA. At the end of the 2nd, 4th, and
7th days of incubation, parasites were collected, washed twice in PBS and stored in RNAlater
(Ambion) until RNA extraction. At the end of the 2nd, 4th and 7th days of incubation the total
number of eggs, the number of parasites attached to the plate and the number of couples still
paired were quantified. For the H3K4me1 and H3K4me2 western blotting, parasites were col-
lected on the 7th day of incubation with dsRNA and stored in PBS at -80˚C. The viability of the
parasites was determined on the 7th day of incubation as described above. Male and female
adult worms were ground with glass beads in liquid nitrogen for 5 minutes. RNA extraction
and cDNA synthesis were performed as described above. qPCR results were analyzed by the
comparative Ct method. Real-time qPCR data were normalized in relation to the level of expres-
sion of the Smp_090920 and Smp_062630 reference genes. The graphs were plotted using
GraphPad Prism 8 software, and statistical significance was calculated with the Student´s t-test.
RNA-Seq data analysis
The general outline of the bioinformatics pipeline used for the analysis of the RNA-Seq data is
completely described in Pereira et al. [36], including the three different statistical approaches that
were used to obtain lists of differentially expressed genes, and considering as the final set only those
genes that were listed at the intersection of the three sets. We used the same versions of genome
and transcriptome annotation, including the use of a metagenes transcriptome to deal with iso-
forms, as previously described [36]. All software parameters were as described [36] except for Trim-
momatic [37] HEADCROP 12 and MAXINFO 60, since we decided to prioritize longer reads.
Each replicate sample of adult worms has generated from 26 to 39 million paired-end 150-bp reads;
for schistosomula, a total of 30 to 40 million reads was obtained per replicate sample. The raw
RNA-Seq data was deposited at NCBI under BioProject Accession number PRJNA361136.
Validation of differential gene expression by qRT-PCR
The selection of the candidates was performed based on the higher differences found in gene
expression between DMSO and MC3935-treated samples. Only genes found up- or down-reg-
ulated in both male and female were selected. The reverse transcription (RT) reaction was per-
formed with 100 ng of each total RNA sample using the SuperScript IV First-Strand Synthesis
System (Life Technologies) and random hexamer primers in a 20 μL final volume. The
obtained complementary DNAs (cDNAs) were diluted 10 times in DEPC water and quantita-
tive PCR was performed using 2.5 μL of each diluted cDNA in a total volume of 10 μL contain-
ing 1X LightCycler 480 SYBR Green I Master Mix (Roche Diagnostics) and 800 nM of each
primer in a LightCycler 480 System (Roche Diagnostics). Primers for all transcripts were
designed using the IDT Real time PCR tool (https://www.idtdna.com/Primerquest/Home/
Index). The sequences of the primers are listed in S12 Table. Each real-time qPCR was run in
three technical replicates. The results were analyzed by comparative Ct method (38). Analysis
of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT
Method. Real-time data were normalized in relation to the level of expression of the
Smp_092920 and Smp_062630 as reference genes. The graphs were plotted using GraphPad
Prism 8 software, and statistical significance was calculated with the Student´s t-test.
Results
Schistosoma mansoni lysine specific-demethylase 1
The Schistosoma mansoni LSD1 (SmLSD1) contains all three canonical structural, and func-
tional domains (SWIRM, amino-oxidase-like and TOWER domains) (Fig 1A) found in the
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LSD1 protein family. We examined in detail the protein alignment between SmLSD1 and
human LSD1 (hLSD1) (S2 Fig), particularly since the latter is a well-defined drug target [18]
and carried out a limited phylogenetic study including further orthologs. In this regard, our
phylogenetic tree revealed that the SmLSD1 protein was closer to human LSD1 than to plant
or nematode LSD1 (Fig 1B). It is worth noting that among the five LSD1 homologs tested only
SmLSD1 presented unique sequences within all LSD1 functional domains (Fig 1A, purple seg-
ments and S2 Fig, dashed lines), which could be explored to develop a S. mansoni-selective
drug.
Fig 1. Overview of SmLSD1 protein domains and conservation. (A). Schematic representation of the full-length
SmLSD1 protein (Smp_150560, top scheme), depicting the conserved functional domains: the SWIRM domain
(orange), amine oxidase-like domain (green), the TOWER domain (blue), and schistosome unique sequences (purple).
The white rectangles depict a less conserved N-terminal domain (15,5% similarity) as well as a highly conserved hinge
region (58,6%) between the SWIRM and amine oxidase-like domains. The full-length of the human LSD1 protein
(bottom scheme) is also shown for comparison. (B). Unrooted phylogenetic tree representation was made using the
ClustalW2 program and visualized with https://itol.embl.de/.https://itol.embl.de/. Tree scale: 0.2.
https://doi.org/10.1371/journal.pntd.0008332.g001
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Viability of Schistosoma mansoni after MC3935 treatment
Schistosomula were obtained by mechanical transformation of cercariae, and adult worms
were recovered by perfusion of infected hamsters (Fig 2A). We screened a series of LSD1
inhibitors (all these small compounds were synthesized based on the scalffold of tranylcypro-
mine (TCP), a well-tested irreversible LSD1 inhibitor) to evaluate their schistosomicidal activ-
ity. All compounds at a final concentration of 25 μM showed toxicity against the juvenile form
of schistosomula at 72 h (S3A Fig) or adult worms at 96 h of cultivation (S3B Fig). Interest-
ingly, TCP showed the least toxic activity, whereas MC3935 was the most potent compound
(S3A and S3B Fig). Therefore, MC3935 was chosen for all further analyses in this study. We
showed that MC3935 was able to inhibit the catalytic activity of the recombinant human LSD1
protein (S1B Fig), revealing a 1,000 fold higher inhibitory activity than TCP, proving it as a
bona fide LSD1 inhibitor. The toxic effect of MC3935 on schistosomula or adult worm pairs
was further confirmed (Fig 2B and 2C and S3C Fig). A significant loss of viability at 25 μM
MC3935 was observed in schistosomula or adult worms after cultivation for 72 or 96 h, respec-
tively (S3C Fig). These results were confirmed with videos (S1–S4 Videos), which showed
nearly 100% of the schistosomula had a complete lack of motility, high granularity and altered
body shape (S2 Video) when compared to healthy schistosomula that were treated with
DMSO only (S1 Video). MC3935-treated-adult worms also showed significant alterations
when compared to the control (Fig 2D and S3 Video), which included unpairing, lack of
adherence, extremely low motility, vitellaria involution and no egg laying (Fig 2D and S4
Video). In order to evaluate whether the lack of eggs (Fig 2D; Egg laying) was exclusively due
to the separation of the worms (Fig 2D; Pairing), we performed an additional experiment in
which only adult worms that were kept coupled were maintained in culture, followed by egg
counting. Worm pairs that were not treated, or treated with DMSO laid a significant number
of eggs, while worm pairs that received the treatment of MC3935 laid no eggs whatsoever (S4A
and S4B Fig).
Molecular docking and catalytic inhibition of SmLSD1 by MC3935
Since no crystal structure of SmLSD1 is yet available, a homology model of the parasite’s
enzyme was first generated using an available crystal structure of the orthologous human
LSD1. By analyzing the reported crystal structures of hLSD1 in complex with covalently
bound tranylcypromine (TCP) derivatives, two crystal structures were found to be most rele-
vant: a crystal structure of the N5 adduct of the highly analogous MC2584, which only lacked
the ethynyl group found in MC3935, and the crystal structure with the N5 adduct of the bulky
tranylcypromine derivative MC2580 (PDB IDs 2XAQ and 2XAS; respectively [29]). The latter
crystal structure (PDB ID 2XAS) was preferred for the use as a template for the homology
model since the conformation of residues Glu682 and Asp669 resulted in a more open binding
site. Sequence alignment of SmLSD1 and hLSD1 showed an overall sequence identity of
44.1%, while the binding site of the FAD-ligand adduct shared an 80.4% sequence identity. In
order to predict the binding mode of MC3935 to SmLSD1, the N5 adduct of this tranylcypro-
mine derivative with the flavin ring of FAD was first generated similar to the N5 adduct of the
analogous MC2584, and docking was subsequently performed into the homology model of
SmLSD1. The obtained docking pose showed that the N5 adduct of MC3935 adopted a similar
orientation in the binding site as observed with MC2584 (Fig 3A) with the ethynyl group
embedded between Glu682 and Asp669. Notably, the binding site of SmLSD1 accommodating
the tranylcypromine part of the adduct shared a 100% homology with the hLSD1 counterpart
(Fig 3B).
PLOS NEGLECTED TROPICAL DISEASES Epigenetic therapy: Targeting histone de-methylation to control schistosomiasis
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008332 July 1, 2020 11 / 29
We next performed western blot analysis and showed that schistosomula or adult worms
treated with MC3935 displayed higher band intensities of H3K4me1 or H3K4me2 marks
when compared to the DMSO controls (Fig 3C), confirming the inhibition of SmLSD1
demethylase activity. Of note, the increase in H3K4me1 or H3K4me2 methylation was not due
to the downregulation of SmLSD1 transcription (S5 Fig, qPCR graphs in A and B). Together,
these data confirm that MC3935 inhibited SmLSD1 demethylase activity. Importantly,
MC3935 treatments did not alter the H3K4me3 mark in schistosomula or adult worms (S5
Fig, western blots in S5A and S5B), pointing to a selective inhibition of LSD1-specific histone
marks.
Apoptosis in S. mansoni after SmLSD1 inhibition
The treatment of schistosomula with MC3935 significantly induced apoptosis, as detected by
the 8-fold increase in the activities of caspases 3 and 7 (Fig 4A). In addition, the TUNEL assay
indicated extensive double-strand DNA breaks (Fig 4B), as revealed by the green staining of
the whole body of the worm treated with the inhibitor. Worms treated with DMSO showed no
apoptotic activity, whatsoever (Fig 4A and 4B). These results are in agreement with our data
from the ATP viability assay (Fig 2B, S3C Fig) and our observations taken from the optical
microscope (S1 and S2 Videos).
Fig 2. LSD1 inhibition is detrimental to Schistosoma mansoni survival. (A). Simplified scheme of the acquisition of the
two developmental stages of the parasite used in this study. Cercariae were harvested from infected snails and used to either
infect hamsters or mechanically transformed into schistosomula for in vitro culture. Hamsters were perfused 42–49 days
postinfection to harvest adult worm pairs. (B). The relative ATP dosage (%) of schistosomula treated with 25 μM MC3935
(green line) was measured every 24 h (up to 96 h). Schistosomula given DMSO or nothing are shown in gray and black lines,
respectively. (C) Relative ATP dosage (%) of adult worm pairs treated with 25 μM MC3935 for 96 h. NT, nontreated adult
worm pairs. The results of three independent experiments are shown, and error bars represent the standard deviation (SD).
(D) Evaluation of the viability of adult worm treated with DMSO or 25 μM MC3935 for 96 h. Several parameters of adult
worm viability were monitored daily until day 4, using an optical microscope equipped with a digital camera. Details for
these classifications are described in the methods section. These viability parameters were reviewed and scored by two
independent observers. Videos of the control or MC3935-treated worms to confirm the described scores are available (in
Supplementary videos). Statistical significance, comparing MC3935-treated and vehicle conditions, was determined using
Student´s t-test, with ����p<0.0001.
https://doi.org/10.1371/journal.pntd.0008332.g002
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Tegumental damage and ultrastructural abnormalities of schistosomula
after SmLSD1 inhibition
The results from our scanning electron microscopy clearly showed that inhibition of SmLSD1
by MC3935 induced severe erosions and fissures in the tegument of schistosomula (Fig 5B and
5D). Worms treated with DMSO revealed the typical healthy status of schistosomula (panel
A), showing preserved tegumental spines (panel C). These images corroborate our conclusions
Fig 3. MC3935 binds to the catalytic pocket of SmLSD1 and inhibits its demethylase activity. (A). In silico molecular docking pose of the N5
adduct of MC3935 (in green) in the homology model of SmLSD1. The experimentally determined binding mode of the analogous MC2584 obtained
by the superposition with the corresponding hLSD1 crystal structure (PD ID 2XAQ) is shown in purple. Only side chains of the SmLSD1 binding
site are shown (white sticks). (B). Overlay of the SmLSD1 homology model (white sticks) showing the predicted binding mode of the MC3935
adduct with hLSD1 (cyan sticks; PDB ID 2XAS). (C) Western blot of total protein extracts from 72-hour-treated schistosomula (left panels) or 96
hour-treated adult worm pairs (right panels). Monoclonal antibodies against H3K4me1, H3K4me2 and H3 (as loading control) were used.
Quantification of the bands (shown above each image) was done by densitometry (ImageJ, NIH software) normalized by the intensity of the H3
band. Western blots were performed from 5 independent biological replicates and one representative is shown here.
https://doi.org/10.1371/journal.pntd.0008332.g003
Fig 4. Inhibition of SmLSD1 triggers apoptosis. Twenty thousand schistosomula were cultivated in the presence of
DMSO or 25 μM MC3935 for 72 h. (A) Caspase 3/7 activity was significantly increased in MC3935-treated parasites
(green bar). Statistical significance, comparing MC3935-treated and vehicle conditions, was determined using Student
´s t-test, with ��p<0.01. (B) TUNEL assay of schistosomula incubated for 72 h with DMSO (left panels) or 25 μM
MC3935 (right panels). Green parasites (lower panel) indicate double-strand DNA breaks. DAPI stains nuclear DNA,
seen in blue (top panels). Scale bar: 50 μm. The images displayed are representative of three independent experiments,
with approximately 20 samples analyzed.
https://doi.org/10.1371/journal.pntd.0008332.g004
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that the MC3935 treatment led to schistosomula death. In this respect, it is reasonable to
assume that the survival of these worms (note in panels B and D the depth of tegumental dam-
age) could not be rescued even by the eventual withdrawal of the inhibitor.
Transmission electron microscopy of DMSO-treated schistosomula revealed preserved
ultrastructures in the worms (Fig 6, panels A, C, E, G and I), such as tegumental spines (black
arrows), outer tegument (�), tegument basal lamina (b), circular muscle (cm), longitudinal
muscle (lm), mitochondria (m) and nuclei (n). In MC3935-treated schistosomula, extensive
ultrastructural disorganization of the tegument was seen, such as a lack of the outer tegument
(Fig 6, panel B, asterisks) and tegumental spines (panel B, black arrow). Significant loss of the
muscle layers was also observed (compare lm and cm in panels A, C with panels B, D). Large
vacuoles were seen in the more external region of the tegument of MC3935-treated parasites
(tv in panel D). Additionally, these internal vacuoles contained what seemed to be cellular
debris (panel D, #), which could be an indication of tissue degradation and cell death. Panel F
shows significant thickening and higher electron density of the outer tegument, associated
with the appearance of projections (white asterisk). Loosening and disorganization of the mus-
cle fibers were also observed (panel F and H, lm, and cm) as were different projections of the
spines in the outer tegument (panel H, white asterisks). Control parasites (panel I) showed
normal and preserved mitochondria (m), always associated with muscle fibers while
MC3935-treated parasites (panel J) showed smaller mitochondria (m) that appeared to have
less well-defined cristae, and enveloped by membranous structures, which could be an indica-
tion of leftover muscle fibers, and they were close to myelin fibers (mf).
Fig 5. Inhibition of SmLSD1 leads to tegumental damage of schistosomula. Schistosomula were treated with 0.25%
DMSO (left columns) or 25 μM MC3935 (right columns) for 48 h. Scanning electron microscopy (SEM) images of the
tegument in lower (A and B) and higher magnification (C and D). Severe tegumental erosions (arrowhead), and
fissures (arrow) are seen at higher magnification (D). Scale bars: white (5 μm) and yellow (1 μm). The images displayed
are representative of three independent experiments, with approximately 20 samples analyzed.
https://doi.org/10.1371/journal.pntd.0008332.g005
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Phenotypic defects of adult S. mansoni after SmLSD1 inhibition
Analysis of the adult male tegument and its oral sucker by scanning electron microscopy
showed significant alterations upon MC3935 treatment (Fig 7, right panels), when compared
to the control worms (Fig 7, left panels). A detailed inspection of the SEM images revealed
extensive damage in the dorsal tegument of the male worms that were treated with the LSD1
inhibitor, with the presence of a large number of blisters (Fig 7B and 7D, yellow arrowheads),
as well as fissures and holes in the tubercles (Fig 7B and 7D, yellow arrows). Blisters and fis-
sures were also seen in the male oral sucker (Fig 7F, yellow arrows, and arrowheads). Confocal
laser scanning microscopy (CLSM) showed important alterations of the sexual organs of
MC3935-treated male or female parasites (Fig 7H and 7J). It is worth noting the deleterious
effect of the LSD1 inhibitor in the involution of the ovary, leading to a reduced number of
mature or immature oocytes (Fig 7, compare panels G and H). The inhibitor also generated
severe disorganization of the testicular lobes, culminating in a significantly reduced number of
spermatocytes (Fig 7, compare panels I and J). Since the treatment of MC3935 significantly
affected the sexual organs of both male and female worms, one should expect that egg produc-
tion would be severely compromised. S3 and S4 Videos display the described phenotypic
abnormalities, which explain the egg laying impairment in MC3935-treated worms. Indeed,
inspection of egg laying by the worms cultivated in the presence of MC3935 revealed an almost
complete lack of eggs (S4A and S4B Fig and S3 and S4 Videos; in the videos, note the presence
of eggs in DMSO-treated worms and a complete lack of eggs in MC3935-treated parasites) a
few hours after the addition of the inhibitor. It is also worth noting the involution of the vitel-
laria in MC3935-treated females (S4 Video).
Changes in gene expression profile upon SmLSD1 inhibition
We performed RNA sequencing (RNA-Seq) analysis to evaluate the effect of LSD1 inhibition
on global gene transcription in S. mansoni. Unsupervised hierarchical clustering analysis of
RNA-Seq data depicted the changes in global gene expression profile in males, females, or
schistosomula upon treatment with MC3935 (Fig 8). Interestingly, inhibition of SmLSD1 sig-
nificantly modulated 3608 transcribed genes in male, female or schistosomula, with 1964
being downregulated, and 1644 being upregulated (Fig 8A). The highest modulation of gene
expression was observed in male worms, for either up- or downregulation (Fig 8A, purple in
the Venn diagram), followed by female worms (Fig 8A, pink in the Venn diagram), and schis-
tosomula (Fig 8A, red in the Venn diagram). Importantly, when we analyzed commonly regu-
lated genes in male, female, or schistosomula, we found 220 and 50 genes down- or
upregulated, respectively (Fig 8A). The complete lists of significantly upregulated genes in
each female, male or schistosomula (S1–S3 Tables), downregulated genes in each females,
males or schistosomula (S4–S6 Tables), down- or upregulated genes in common between
females and males (S7 and S8 Tables, respectively) are presented in the supporting informa-
tion. It is noteworthy that in schistosomula, a smaller number of consensus of differentially
expressed genes (DEGs) was detected when compared with adult worms (Fig 8A).
A clear profile of the differential gene expression between control and MC3935-treated par-
asites is depicted in the heatmap (Fig 8B), which confirmed that the treatment led to a signifi-
cant change in the regulation of genes in females, males and schistosomula, with many genes
being either up- (Fig 8B, red) or downregulated (Fig 8B, blue).
A closer look at the twenty most differentially expressed genes in females, males or schisto-
somula revealed that inhibition of SmLSD1 by MC3935 changed the levels of expression of
genes belonging to different critical biological processes, including protein and lipid degrada-
tion, RNA processing, calcium and sodium homeostasis, antioxidants and transcription factors
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(S9–S11 Tables). Within this list, genes encoding proteases stood out as being downregulated
in MC3935-treated schistosomula, males and females as compared to DMSO-treated parasites
(S9–S11 Tables, shaded in green). Genes encoding protease inhibitors were upregulated in
females and males (S9 and S10 Tables, shaded in dark green). Importantly, genes of the diges-
tive system of S. mansoni were found down- or upregulated (S9–S11 Tables, shaded in green
with �).
Genes encoding kinases and phosphatases were upregulated in treated females and males
(S9 and S10 Tables, shaded pink and yellow, respectively). Overall, the analysis of the twenty
most differentially expressed genes in treated males revealed a more heterogeneous gene
expression profile (S10 Table). Of note, in MC3935-treated schistosomula, a significant num-
ber of genes encoding proteins involved in RNA metabolism were upregulated (S11 Table,
shaded in blue). Downregulated genes encoding proteases stood out in treated schistosomula
(S11 Table, shaded in green).
For gene expression validation, we performed qRT-PCR on the samples submitted to RNA
sequencing as well as on cDNA samples from DMSO- or MC3935-treated adult worms (S6
Fig). We selected a set of twelve genes (6 up- and 6 down-regulated) out of the twenty most dif-
ferentially expressed genes in females and males (S9 and S10 Tables). Importantly, 100% of the
genes selected from our RNA-Seq analysis were validated with high significance (S6A and S6B
Fig, TPM values). These same twelve genes were used for validation on cDNAs from samples
treated under the same conditions of the RNA-Seq experiment (25 μM of MC3935 for 48 h).
Again, nearly all the genes were validated for differential expression, with the exeption of
Smp_139160 and Smp_166530 that although did not show significance, point to a clear ten-
dency for down-regulation (S6 Fig, Relative expression). Noteworthy, these validations indi-
cate specificity of gene targeting by MC3935, as well as the robustness of our analysis.
Knockdown of the SmLSD1 gene
We conducted dsRNAi experiments in adult worm pairs and were able to achieve 70% silenc-
ing of SmLSD1 transcription at day 7 (S7A and S7B Fig). Western blot analysis of protein
extracts from silenced adult worm pairs revealed a 2-fold inhibition of SmLSD1 demethylase
activity (S7C Fig). By monitoring the behavior of the worms on a daily basis, we clearly
observed progressive harm in whole-worm physiology during SmLSD1 silencing, which cul-
minated in significant unpairing of male and female worms, a decrease of nearly 50% in the
number of laid eggs, low motility and compromised surface adherence by the oral sucker of
male worms (S7D–S7F Fig). Silencing of SmLSD1 promoted damage to the oral sucker of male
worms (S7G Fig). Of note, the silencing of the parasites with the control dsRNAi showed no
Fig 6. Inhibition of SmLSD1 leads to ultrastructural abnormalities in schistosomula. Transmission electron
microscopy (TEM) of schistosomula treated with 0.25% DMSO (left column, panels A, C, E, G and I) or 25 μM
MC3935 (right column, panels B, D, F, H and J) for 48 h. Symbols are as follows: tegumental spines (black arrows),
outer tegument (�), tegument basal lamina (b), circular muscle (cm), longitudinal muscle (lm), mitochondria (m) and
nucleus (n). In MC3935-treated schistosomula, an ultrastructural disorganization of the tegument is seen, lacking the
outer tegument and tegumental spines (panel B, black arrow). A complete lack of the muscle layers (lm or cm) is also
noted (panel B). Large vacuoles are observed in the more external region of the tegument of MC3935-treated parasites
(panel D, tv). Internal vacuoles contain cellular debris (panel D, #). Significant thickening and higher electron density
of the outer tegument is present, associated with the appearance of projections (panel F, white asterisk). Loosening and
disorganization of the muscle fibers (panel F and H, lm and cm) and uncommon projections of the spines in the outer
tegument (panel H, white asterisks) are observed. Control parasites (panel I) show normal and preserved mitochondria
(m), always associated with muscle fibers (lm or cm). MC3935-treated parasites (panel J) lack muscle fibers, and they
show smaller mitochondria (m) that appear to have less defined cristae, to be enveloped by membranous structures
and to be close to myelin fibers (mf). Scale bars: white (5 μm) and yellow (1 μm). The images displayed are
representative of three independent experiments, with approximately 20 samples analyzed.
https://doi.org/10.1371/journal.pntd.0008332.g006
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decrease in SmLSD1 gene expression or activity and no deleterious effects in the worms (S7
Fig, dsGFP).
The twelve differentially expressed genes validated by qRT-PCR from the RNA-Seq analysis
(S6A and S6B Fig) were tested in the samples obtained from the RNAi experiment, and we
could confirm only one down-regulated gene (Smp_156960) (S8 Fig). Although curious, this
was not a surprising result, if one considers that there are some caveats involved when dealing
with gene silencing by RNA interference, such as partial reduction of the target mRNA levels,
and partial reduction in the level of the respective protein due to its possibly low turnover rate.
In the case of SmLSD1, we achieved 70% of mRNA silencing, which still leaves 30% of the mes-
sage to be translated and possibly leaving a considerable amount of LSD1 enzymatic activity
for transcriptional regulation. This phenomenon can be easily verified when comparing the
levels of mono and dimethylation of histone H3 lysine 4 in the adult worm samples from
MC3935 and dsRNA targeting LSD1. We found 4.16-fold increase in H3K4me1 signal in the
MC3935-treated worms compared with only a 2.06-fold increase in the dsRNA treated worms.
The same was observed in the H3K4me2 signal, where MC3935-treated adult worms presented
a 2.76-fold increase in the histone mark whilst dsRNA treated adult worms presented only a
1.84-fold increase in this signal.
Given the fact that the RNA-Seq analysis of the effect of MC3935 has shown that treatment
with the drug promotes a broad change in the transcriptional program of the parasite, which
affected a number of different metabolic pathways, it is possible that when selecting in a some-
what arbitrary manner the 12 genes that were picked for qPCR validation, we have not hit the
set of genes that were most relevant for the phenotypic changes observed by RNAi of SmLSD1.
Nevertheless, SmLSD1 silencing was able to affect the physiology of the parasite (Fig 7E–
7G), suggesting that a minimum interference in control of the parasite’s transcriptional pro-
gram is already detrimental to the worms, in vitro.
Discussion
Lysine-specific demethylase 1 (LSD1) is an epigenetic enzyme that oxidatively cleaves methyl
groups from mono and dimethyl Lysine 4 of histone H3 (H3K4me1/2) and can contribute to
gene silencing [13,38–40]. Since its discovery, LSD1 histone demethylase activity has been
investigated as a pharmacologic target for cancer and other diseases. As part of a continuing
effort of several different investigators to identify epigenetic modifications as therapeutic tar-
gets to control schistosomiasis, a recent paper published during our study also identified S.
mansoni LSD1 (SmLSD1) as an additional promising drug candidate [17]. In the present
study, we provide evidence that SmLSD1 plays important biological roles in the physiology of
S. mansoni and that inhibition of SmLSD1 by a novel, selective, and potent LSD1 synthetic
inhibitor MC3935 is detrimental to the survival of juvenile and adult worms.
MC3935 was synthesized based on the scaffold of the nonselective and irreversible mono-
amine oxidase (MAO) inhibitor tranylcypromine (TCP) [29,41]. Tranylcypromine is a mecha-
nism-based suicide inhibitor of MAO and LSD1; it covalently binds to the FAD cofactor
Fig 7. Inhibition of SmLSD1 leads to tegumental damage and reproductive organ involution in adult
schistosomes. Ten adult worm pairs were cultivated in the presence of DMSO (left column) or 25 μM MC3935 (right
column) for 72 h. Scanning electron microscopy (SEM) images from the dorsal region of male worms show damage to
the tegument (B), tuberculous (D) and oral sucker (F) compared to controls (A, C and E). Yellow arrows point to
fissures and arrowheads point to blisters. Scale bar: 2 μm (yellow). Confocal laser scanning microscopy (CLSM) of
ovaries (G and H) and testis (I and J) from control and MC3935-treated, respectively. OV: ovary; mo: mature oocytes;
io: imature oocytes; (t) testicular lobes; sv: seminal vesicle; s: spermocytes. Scale bars: 20 μm (white) and 2 μm (yellow).
The images displayed are representative of three independent experiments, with approximately 20 samples analyzed.
https://doi.org/10.1371/journal.pntd.0008332.g007
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Fig 8. Inhibition of SmLSD1 triggers genome-wide transcriptional deregulation. RNA-Seq analysis of female and male worms and
schistosomula that were cultivated in the presence of DMSO (control) or MC3935 (25 μM) for 48 hours. (A) Venn diagrams of the number of
genes that were detected as differentially expressed among female, male and schistosomula. The numbers at the intersections (darkest red) of the
diagrams represent genes commonly affected in the presence of MC3935 among females (purple), males (blue) and schistosomula (red) (220
downregulated genes and 50 upregulated genes). (B) The heatmaps show the hierarchical clustering of differentially expressed genes (columns) in
four biological replicates (lines) of female and male worms, and schistosomula, either for controls or for treated parasites, as indicated on the left
side of the heatmaps. Blue lines, downregulated genes. Red lines, upregulated genes. Gene expression levels are shown as Z-scores, which
represent the number of standard deviations above (red) or below (blue) the mean expression value among treated and control samples for each
gene; the expression level Z-scores are color-coded as indicated on the scale at the right side of the heatmap.
https://doi.org/10.1371/journal.pntd.0008332.g008
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embedded within the protein, thus abolishing enzymatic catalysis [42]. Importantly, MC3935
showed a 1,000 fold higher inhibitory activity than TCP, in vitro. In addition, our in silico
molecular docking indicated that MC3935 could indeed be an effective SmLSD1 inhibitor and
that the inhibition also relied on the amino-oxidase-like catalytic domain. Toxicity assays on S.
mansoni parasites using each of our 11 synthetic putative LSD1 inhibitors, as well as TCP,
revealed MC3935 as the most powerful, with TCP showing the lowest toxicity toward the
worms. This was a surprising result if we consider that both MC3935 and TCP [43] should
adopt a similar orientation in their binding to the catalytic site of SmLSD1, based on our in sil-
ico molecular docking. However, one could always assume that the lack of toxicity of TCP was
due to its lower permeability to the tegument of S. mansoni or that it is more metabolically
labile. Indeed, MC3935 fills better the catalytic tube of the enzyme better than TCP, due to its
addiotional ethynylbenzamide portion, which allows additional interaction within the tube.
Importantly, our western blot analyses indicated that MC3935 specifically inhibited H3K4
mono- and dimethylation, which are known LSD1 targets, but not H3K4 trimethylation, a
mark that is targeted by the histone demethylases of the Jumonji family [44].
Genetic studies in numerous models have suggested that LSD1 plays a significant role in
developmental processes [45]. LSD1 has also been reported to have a role in the DNA damage
response [46], repression of mitochondrial metabolism, lipid oxidation energy expenditure
programs [47,48], and smooth muscle regeneration [49]. Additionally, germline murine
knockouts exhibit embryonic lethality before E7.5: the egg cylinder fails to elongate and gastru-
late, resulting in development arrest [50]. In C. elegans, the homolog spr-5 regulates Notch sig-
naling [51,52], and maintains transgenerational epigenetic memory and fertility [53]. The
yeast spLsd1/2 [54] and Drosophila Su(var)3-3 [55] homologs regulate gene silencing, which is
required to guarantee normal oogenesis [56] and spermatogenesis [57] in Drosophila.
Taking into account the phenotypic effects observed in schistosomula or adult worms
under the treatment with the LSD1 inhibitor MC3935, it can be assumed that SmLSD1 also
plays important roles in the development and homeostasis of the tegument, muscle and sexual
organs of S. mansoni. Although inhibition of SmLSD1 can have more pronounced effects on
many other key biological processes or structures in S. mansoni, the tegument disruption
would alone represent a desirable LSD1 target. The tegument of S. mansoni plays a crucial role
in its protection against the host immune system [58]; it is capable of absorbing nutrients and
molecules, as well as excreting metabolites and synthesizing proteins [59,60]. Inhibition of
SmLSD1 activity, either by irreversible MC3935 binding or by partial knockdown of the
SmLSD1 gene, generated pronounced damage in schistosomula or adult worms (Fig 5, Fig 7,
and S7 Fig), which likely made a major contribution to the observed mortality of the parasites
within a short period of time (Fig 2, Fig 4, S3 Fig, S7 Fig, and supplementary videos).
The musculatory activity is essential in several aspects of S. mansoni biology and physiology,
including infection, pairing, feeding, regurgitation, reproduction and egg laying [61–63]. Our
transmission electron microscopy revealed a complete lack of muscle layers in schistosomula
treated with the LSD1 inhibitor (Fig 6), which was accompanied by phenotypic defects
observed in treated-worms, such as lack of motility, sucker adherence, egg laying and vitellaria
contraction (Fig 2, S4 Fig and S4 Video), that could be related to the compromised muscle
structures.
Interestingly, the role of LSD1 in oogenesis and spermatogenesis seems to be conserved
among different organisms, including human, C. elegans, Drosophila, and S. mansoni (this
paper). Our confocal microscopy revealed significant alterations in the sexual organs of treated
worm pairs, such as a reduced number of spermatocytes and oocytes (Fig 7H and 7J). These
data are in agreement with the incapacity of the worms to produce eggs, even when remaining
paired during the treament (see S4 Fig).
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Several diseases have been associated with aberrant histone methylation/demethylation pat-
terns. Thus, considering that juvenile or adult S. mansoni are highly transcriptionally active
and that SmLSD1 is expected to control the expression of a variety of different genes to main-
tain the homeostasis of the parasites, we compared their global transcriptional profiles after
incubation with a sublethal dose of MC3935. Our RNA-Seq analysis revealed that inhibition of
SmLSD1 led to the differential expression of genes involved in several different biological pro-
cesses. These data suggest that SmLSD1 is recruited to target gene promoters by different tran-
scription factors. Among the genes that were downregulated upon SmLSD1 inhibition in
schistosomula, females and males, several proteases stood out (S9–S11 Tables, shaded in
green), mainly from the cathepsin family, including two hemoglobinases in female worms.
This is an important finding considering that proteases are key components of the pathogenic-
ity of the parasite; they facilitate tissue penetration and determine the nutritional sources of
the parasite within intermediate and human hosts [64]. Importantly, two protease inhibitors
were upregulated in females and males (S9 and S10 Tables, shaded in dark green). That
SmLSD1 controls the expression of genes of the digestive system of female or male worms was
supported by the fact that a number of genes encoding enzymes or proteins of the digestive
tract of the parasite [65] had modified expression in treated parasites (S9–S11 Tables, shaded
in green and with �). In this regard, it is noteworthy that blood digestion seemed to be severely
compromised in females (see S4 Video).
Interestingly, we identified the SMDR2 gene as significantly downregulated in female
worms treated with the LSD1 inhibitor (S9 Table, shaded in green and with #). SMDR2 is the
schistosome homolog of P-glycoprotein (PgP) [66], an ATP-dependent efflux pump, and its
downregulation upon treatment might be involved in the high toxicity of MC3935 observed in
females (see S4 Video).
Importantly, a significant number of proteins involved in RNA metabolism seemed to be
specifically upregulated in schistosomula (S11 Table, shaded in blue). This finding is of great
importance since, although histone methylation has been only recently coupled to RNA pro-
cessing [67], this is the first report suggesting a role for LSD1 in regulating RNA metabolism.
The present study further suggests SmLSD1 is a promissing candidate as a drug target.
More generally, the epigenetic regulation of chromatin affects many fundamental biological
pathways. Therefore, the realization that the deregulation of chromatin is harmful to S. man-
soni should reinforce significant efforts to develop selective epigenetic drugs against schistoso-
miasis. Although the results obtained do not allow us to pinpoint a specific mechanism to
explain the toxicity of the inhibitor, and we cannot rule out some off-target effects.
Supporting information
S1 Fig. Synthesis and IC50 of MC3935. (A). Compound 1 (MC3935) was synthesized by cou-
pling racemic tert-butyl (trans-2-(4-(4-ethynylbenzamido)phenyl)cyclopropyl) carbamate 2,
prepared as previously reported,1 with the commercially available 4-ethynylbenzoic acid fol-
lowed by acidic deprotection of the Boc protected amine 3. Reagents for the synthesis of com-
pound 1 (MC3935): (a) HOBt, EDCI, TEA, dry DMF, rt; (b) HCl 4N in dioxane, dry THF,
0˚C-rt. (B). MC3935 inhibits the catalytic activity of recombinant human LSD1 (hLSD1). The
concentration required to inhibit the activity of the purified hLSD1 protein by 50% (IC50) is
shown in the graph. (C). Schistosomula viability is impaired by MC3935 treatment. The con-
centration required to cause mortality in 50% of the parasites (IC50) after 48 hours is shown in
the graph.
(TIF)
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S2 Fig. Schistosoma mansoni LSD1 protein alignment. Sequence alignment using the Clustal
Omega tool was performed including the Homo sapiens—NP_055828, and Schistosoma man-
soni–XP_018652619.1. The functional domains of the LSD1 protein family are underlined as
follows: the SWIRM domain in orange (165–287 aa), the amino-oxidase-like domain in green
(379–824 and 909–1136 aa) and the TOWER domain in blue (825–908 aa). Amino acid posi-
tions refer to the SmLSD1 protein. Unique amino acid sequences found within the SmLSD1
polypeptide are shown as dashes.
(TIF)
S3 Fig. Screening of synthetic small LSD1 inhibitors in Schistosoma mansoni. Twenty thou-
sand schistosomula (A) or ten adult worm pairs (B) were incubated with 25 μM of LSD1 inhib-
itors or DMSO (nontreated parasites were included as an additional control) and submitted to
an ATP cell viability assay. Tranylcypromine (TCP, red bars) is a well-known irreversible
LSD1 inhibitor. Twelve different compounds based on the TCP scaffold were tested. (C) Dose-
dependent toxicity of MC3935 (at 1, 10 or 25 μM) on schistosomula or adult worm pairs. Incu-
bation times for schistosomula and adult worms were 72 h and 96 h, respectively. The results
of three independent assays are shown; error bars represent the SD. Statistical significance,
comparing treated and vehicle conditions, was determined using one-way ANOVA, with
�p<0.05, ��p<0.01 and ����p<0.0001, and ns standing for non-significant.
(TIF)
S4 Fig. LSD1 inhibition affects egg production. (A). Adult worm pairs were treated (or not,
NT) with 0.25% DMSO or 25 μM MC3935 and cultivated for 96 h. The number of laid eggs
was counted daily and a representative image was recorded. Scale bar: 250 μm. (B). Quantifica-
tion of eggs normalized by the number of adult worm pairs and days of treatment. Statistical
significance, comparing MC3935-treated and vehicle conditions, was determined using Stu-
dent´s t-test, with ����p<0.0001.
(TIF)
S5 Fig. SmLSD1 inhibition by MC3935 has no effect on H3K4 trimethylation in schisto-
somes. Quantitative RT-PCR analysis of SmLSD1 mRNA or western blot analyses of SmLSD1
protein from schistosomula (A) or adult worms (B) after 72 h or 96 h incubation time with
MC3935, respectively. The bars indicate standard deviations from three independent measure-
ments. Histone H3 was included in western blots as the loading control. Statistical significance,
comparing MC3935-treated and vehicle conditions, was determined using Student´s t-test,
with ns standing for non-significant.
(TIF)
S6 Fig. Validation of gene expression data by quantitative reverse transcriptase-real time
PCR. The expression of twelve selected genes was measured by qRT-PCR in RNA samples
extracted from male or female parasites exposed for 48 h in vitro either to DMSO (gray bars)
or 25 μM of MC3935 (green bars). Top panels in A or B show the validation of down-regulated
or up-regulated genes, respectively, from samples submitted to RNA-Sequencing (TPM val-
ues). Bottom panels in A or B show the validation of down-regulated or up-regulated genes,
respectively, from samples submitted to cDNA synthesis (Relative expression 2⌃ΔCt). Expres-
sion was normalized as indicated in the Methods, and the lowest normalized value among the
control biological replicates was chosen as reference and arbitrarily set to 1. Relative expression
of all other control and treated samples was calculated in relation to that value. Graphs show
the mean +_ S.D. of four biological replicates for each condition in males and females. Statisti-
cal significance, comparing MC3935-treated and vehicle conditions, was evaluated with the
Student´s t-test and significant changes are marked by asterisk with �p<0.05, ��p<0.01,
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���p<0.001 and ����p<0.0001. Down-regulated genes: Smp_055780: smdr2; Smp_085180:
cathepsin B (C01 family); Smp_126120: LAMA protein 2; Smp_014570: Saposin1;
Smp_139160: SmCL2 peptidase (C01 family); Smp_166530: phospholipase A. Up-regulated
genes: Smp_034500: Dual specificity protein phosphatase 10; Smp_147730: single Kunitz pro-
tease inhibitor; Smp_025390: putative calcium dependent protein kinase; Smp_128550: src
type protein tyrosine kinase; Smp_094930: early growth response protein 1; Smp_047660: ferri-
tin2C heavy polypeptide 1.
(TIF)
S7 Fig. SmLSD1 knockdown partially recapitulates MC3935 phenotypes in adult worms.
(A). Adult worm pairs were soaked with 30 μg of dsDNA and cultivated for up to 7 days. A
silencing of 70% was obtained for SmLSD1 mRNA at day 7 (panels A and B). (C) Western blot
analysis of total protein extracts from GFP- or SmLSD1-silenced worms at day 7. Band inten-
sity quantifications (obtained with Image J) are shown above each image, and they were nor-
malized by the H3 band. (D and E) Egg production by GFP- or SmLSD1-silenced female
worms was monitored daily (scale bar = 200 μm). (F) Several parameters for adult worm via-
bility were monitored daily using a light microscope, until day 7. The viability parameters
were reviewed and scored by two independent observers. (G) SmLSD1 RNAi-mediated pheno-
typic effects observed by scanning electron microscopy. Arrows point to fissures and arrow-
heads to blisters in the oral sucker of male worms (scale bar = white (5 μm) and yellow (1 μm).
Statistical significance was determined using one-way ANOVA, with ��p<0.01, ���p<0.001
and ����p<0.0001. The images displayed are representative of three independent experiments,
with approximately 20 samples analyzed.
(TIF)
S8 Fig. Validation of gene expression data by quantitative reverse transcriptase-real time
PCR. Panels A and B show the expressions of selected genes that were measured by qRT-PCR.
The cDNA samples were from adult S. mansoni incubated for seven days with double-stranded
RNA interference for the SmLSD1 gene or the negative control GFP gene. The methodology
of the qRT-PCR and the twelve selected genes (Smp) were the same as described in S7 Fig. Sta-
tistical significance was evaluated with the Student’s t-test and significant changes are marked
by asterisk with �p<0.05.
(TIF)
S1 Table. List of upregulated genes on MC3935-treated female adult worms.
(XLSX)
S2 Table. List of upregulated genes on MC3935-treated male adult worms.
(XLSX)
S3 Table. List of upregulated genes on MC3935-treated schistosomula.
(XLSX)
S4 Table. List of downregulated genes on MC3935-treated female adult worms.
(XLSX)
S5 Table. List of downregulated genes on MC3935-treated male adult worms.
(XLSX)
S6 Table. List of downregulated genes on MC3935-treated schistosomula.
(XLSX)
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S7 Table. List of commonly downregulated genes on MC3935-treated male and female
adult worms.
(XLSX)
S8 Table. List of commonly upregulated genes on MC3935-treated male and female adult
worms.
(XLSX)
S9 Table. List of the 20 most differently expressed genes on MC3935-treated female adult
worms.
(DOCX)
S10 Table. List of the 20 most differently expressed genes on MC3935-treated male adult
worms.
(DOCX)
S11 Table. List of the 20 most differently expressed genes on MC3935-treated schistoso-
mula.
(DOCX)
S12 Table. List of primers.
(DOCX)
S1 Video. Schistosomula treated with DMSO for 48 h.
(AVI)
S2 Video. Schistosomula treated with MC3935 for 48 h.
(AVI)
S3 Video. Adult worms treated with DMSO for 96 h.
(MP4)
S4 Video. Adult worms treated with MC3935 for 96 h.
(MP4)
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